These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2782598)

  • 41. Effectiveness of laser photobiomodulation at 660 or 780 nanometers on the repair of third-degree burns in diabetic rats.
    Meireles GC; Santos JN; Chagas PO; Moura AP; Pinheiro AL
    Photomed Laser Surg; 2008 Feb; 26(1):47-54. PubMed ID: 18248161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of hypotension during propofol induction: a comparison of preloading with 3.5% polymers of degraded gelatin (Haemaccel) and intravenous ephedrine.
    Dhungana Y; Bhattarai BK; Bhadani UK; Biswas BK; Tripathi M
    Nepal Med Coll J; 2008 Mar; 10(1):16-9. PubMed ID: 18700624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Does gelatin as a blood substitute selectively depress plasma fibronectin? A clinical randomized study].
    Lackner F; Graninger W; Khosropour R
    Anaesthesist; 1985 Sep; 34(9):470-3. PubMed ID: 3909842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The effect of basic fibroblast growth factor on myofibroblasts and its significance on wound healing].
    Cheng B; Fu X; Sheng Z; Gu X; Sun T; Sun X
    Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1187-91. PubMed ID: 12475407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of tumor necrosis factor-alpha on wound healing. An experimental study.
    Rapala K
    Ann Chir Gynaecol Suppl; 1996; 211():1-53. PubMed ID: 8790842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of gelatin-based resuscitation fluids on platelet aggregation.
    Evans PA; Glenn JR; Heptinstall S; Madira W
    Br J Anaesth; 1998 Aug; 81(2):198-202. PubMed ID: 9813523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversal of opsonic deficiency in surgical, trauma, and burn patients by infusion of purified human plasma fibronectin. Correlation with experimental observations.
    Saba TM; Blumenstock FA; Shah DM; Landaburu RH; Hrinda ME; Deno DC; Holman JM; Cho E; Dayton C; Cardarelli PM
    Am J Med; 1986 Feb; 80(2):229-40. PubMed ID: 3946437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibronectin profiles in normal and chronic wound fluid.
    Wysocki AB; Grinnell F
    Lab Invest; 1990 Dec; 63(6):825-31. PubMed ID: 2255189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic removal of 125I-DLT gelatin after burn injury: a model of soluble collagenous debris that interacts with plasma fibronectin.
    Blumenstock FA; La Celle P; Herrmannsdoerfer A; Giunta C; Minnear FL; Cho E; Saba TM
    J Leukoc Biol; 1993 Jul; 54(1):56-64. PubMed ID: 8336079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Fibronectin content in wound secretions as a criterion of the course of wound healing].
    Kotschnew OS; Ismailow SG; Litwinow RI; Ermolin GA; Efremow EE; Zubairow DM
    Zentralbl Chir; 1991; 116(17):1027-32. PubMed ID: 1746177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibronectin is an acute phase reactant in mice.
    Dyck RF; Rogers SL
    Clin Invest Med; 1985; 8(2):148-51. PubMed ID: 2421956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of fiber and dye degradation products (FDP) on burn wound healing.
    Knox FS; Wachtel TL; McCahan GR; Knapp SC
    Aviat Space Environ Med; 1979 Oct; 50(10):1007-15. PubMed ID: 518442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opsonic fibronectin deficiency and sepsis. Cause or effect?
    Lanser ME; Saba TM
    Ann Surg; 1982 Mar; 195(3):340-5. PubMed ID: 7059244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clearance from the vascular compartment of endogenously labelled plasma fibronectin.
    Deno DC; Lewis EP; Saba TM
    J Trauma; 1984 Feb; 24(2):91-8. PubMed ID: 6694247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood-borne fragments of fibronectin after thermal injury.
    La Celle P; Blumenstock FA; Saba TM
    Blood; 1991 May; 77(9):2037-41. PubMed ID: 2018840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of a synthetic polypeptide on the renal handling of protein in man.
    Beetham R; Dawnay A; Cattell W
    Clin Sci (Lond); 1987 Feb; 72(2):245-9. PubMed ID: 3545643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decrease of plasma fibronectin concentration following infusion of a gelatin-based plasma substitute in man.
    Brodin B; Hesselvik F; von Schenck H
    Scand J Clin Lab Invest; 1984 Oct; 44(6):529-33. PubMed ID: 6207588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood-borne collagenous debris complexes with plasma fibronectin after thermal injury.
    La Celle P; Blumenstock FA; McKinley C; Saba TM; Vincent PA; Gray V
    Blood; 1990 Jan; 75(2):470-8. PubMed ID: 2295002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced quality of clot formation with gelatin-based plasma substitutes.
    Mardel SN; Saunders FM; Allen H; Menezes G; Edwards CM; Ollerenshaw L; Baddeley D; Kennedy A; Ibbotson RM
    Br J Anaesth; 1998 Feb; 80(2):204-7. PubMed ID: 9602586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin.
    Grinnell F; Zhu M
    J Invest Dermatol; 1994 Aug; 103(2):155-61. PubMed ID: 8040604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.